Sublingual Semaglutide and Tirzepatide are now available! Get Started
Dashboard
Formulas

Dihydroergotamine Mesylate 3 mg Slow Release Capsules

Bayview Pharmacy's Dihydroergotamine Mesylate 3 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. This formulation is used to treat conditions such as migraine, cluster headache, Meniere's disease, post-traumatic headache, and tension headache. The slow release mechanism also reduces dosing frequency and improves patient compliance for medications requiring a controlled and prolonged release profile.

Want a different strength?
Click the Text Us button below.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Must be E-Prescribed
Get Started
Generate LeafletShow Leaflet
This medication requires a prescription from your doctor
Are you a prescriber? Sign Up
Trusted by 60,357 patients to date.
A group of faces of our past satisfied patients.
A svg symbol of a mortar and pestle with ingredients going in.
Custom made in our compounding labs.
Sliders that show the customization of ingredients.
Personalized treatment for better results.
User with a gear showing the personalization of the formulation.
All strengths and ingredients are tailored to your needs.
This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.
Slow Release Capsules
6427079ea643246fb75189dc
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Dosing Calculator

Get general dosing information for a patient by using this calculator.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Formula Information

A small arrow pointing down

Dihydroergotamine Mesylate 3 mg Slow Release Capsules is a specialized prescription medication primarily used for the treatment of migraine headaches. It functions by constricting the blood vessels surrounding the brain, thereby alleviating the pain associated with migraines. This particular formulation is engineered with Methocel E4M, a type of controlled-release polymer, which ensures a gradual release of the encapsulated medication over an extended period. This slow-release mechanism allows for sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.

However, this formulation is not recommended for all patients. Those with certain medical conditions, such as uncontrolled high blood pressure, ischemic heart disease, or peripheral vascular disease, should avoid this medication. Additionally, it is contraindicated for patients currently taking certain medications, including ergotamine, ergonovine, or methylergonovine. It is crucial that patients adhere strictly to the dosage and administration instructions provided by their healthcare provider to avoid potential serious side effects.

Common side effects of Dihydroergotamine Mesylate 3 mg Slow Release Capsules include nausea, vomiting, dizziness, and drowsiness. However, these side effects are generally manageable and should subside as the body adjusts to the medication. If these side effects persist or worsen, patients should immediately consult their healthcare provider.

At Bayview Pharmacy, we are committed to providing our patients with this advanced formulation of Dihydroergotamine Mesylate 3 mg Slow Release Capsules. We encourage patients to reach out to us with any questions or concerns regarding this medication or its use. Our team is always ready to provide the necessary guidance and support to ensure optimal patient care and satisfaction.

Drug Interactions

A small arrow pointing down

Dihydroergotamine Mesylate 3 mg Slow Release Capsules are a specialized formulation designed for the treatment of migraine headaches, cluster headaches, and other vascular headaches. This formulation utilizes Methocel E4M, a controlled-release polymer, to gradually release the encapsulated medication over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, making it an ideal choice for medications requiring a controlled and prolonged release profile.

It is crucial to note that this formulation is not intended for the treatment of other types of headaches, such as tension headaches, nor should it be used to treat any other medical conditions. Patients should be aware of potential interactions with other medications they may be taking, including ergot alkaloids, macrolide antibiotics, HIV protease inhibitors, serotonin reuptake inhibitors, and certain antifungal medications. Additionally, this formulation may interact with certain foods, such as aged cheeses, red wine, and certain types of fish.

Patients should also be aware that this formulation may cause side effects such as drowsiness, dizziness, and blurred vision. It is advised not to drive or operate machinery until the effects of this medication are fully understood. Prescribers should also be aware of these potential interactions and side effects when considering this formulation for their patients.

If you have any questions about the interactions or side effects of Dihydroergotamine Mesylate 3 mg Slow Release Capsules, please do not hesitate to reach out for further information.

How Does it Work

A small arrow pointing down

Dihydroergotamine Mesylate 3 mg Slow Release Capsules are a specialized formulation designed to treat various types of headaches, including migraines and cluster headaches. The active ingredient, Dihydroergotamine Mesylate, functions by constricting the blood vessels in the brain, reducing inflammation, and inhibiting the release of certain natural substances that trigger pain. This medication also aids in alleviating associated symptoms such as nausea and sensitivity to light and sound.

This particular formulation employs Methocel E4M, a controlled-release polymer, to encapsulate the medication. This design ensures a gradual and sustained release of the active ingredient over an extended period, providing a steady therapeutic effect. This slow-release mechanism reduces the need for frequent dosing and enhances patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.

When using Dihydroergotamine Mesylate 3 mg Slow Release Capsules, adherence to the prescribed instructions is crucial. The capsules should be consumed with food or milk to minimize the potential for stomach upset. Consistency in the timing of dosage is also important to maintain a steady level of medication in the body. It is advised to abstain from alcohol while on this medication, as it may heighten the risk of side effects.

Side effects such as nausea, vomiting, dizziness, drowsiness, and dry mouth may occur. In the event of experiencing any side effects, immediate contact with a healthcare professional is recommended. This formulation is designed with patient safety and efficacy in mind, and any concerns or queries regarding its use should be directed to a healthcare provider.

Other Uses

A small arrow pointing down

Dihydroergotamine Mesylate 3 mg Slow Release Capsules are a specialized formulation designed to gradually release the active ingredient over an extended period. This is achieved through the use of Methocel E4M, a controlled-release polymer. The slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.

While primarily used for the treatment of migraines, Dihydroergotamine Mesylate 3 mg Slow Release Capsules have also been used off-label for the management of other headache disorders. These include chronic daily headache, hemicrania continua, and new daily persistent headache. Additionally, it has been utilized to alleviate symptoms such as vertigo, nausea, and vomiting that are often associated with migraines.

Furthermore, Dihydroergotamine Mesylate 3 mg Slow Release Capsules may serve as a prophylactic treatment for a variety of conditions. These include migraine, cluster headache, Meniere's Disease, post-traumatic headache, and tension headache. However, it is crucial to understand that the safety and efficacy of this formulation for these off-label uses have not been definitively established.

Patients considering this formulation for off-label uses should engage in a thorough discussion of the potential risks and benefits with their healthcare provider. If you have any questions or concerns about the use of Dihydroergotamine Mesylate 3 mg Slow Release Capsules for any of these conditions, it is recommended that you seek professional medical advice.

Frequently Asked Questions

A small arrow pointing down

What is Dihydroergotamine Mesylate 3 mg Slow Release Capsules?

Dihydroergotamine Mesylate 3 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to gradually release the active ingredient over an extended period of time.

What is the purpose of the controlled-release polymer in this medication?

The controlled-release polymer, Methocel E4M, is designed to release the encapsulated medication gradually over an extended period of time. This offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance for medications requiring a controlled and prolonged release profile.

What are the benefits of a slow-release formulation?

A slow-release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.

How does the slow-release mechanism work?

The slow-release mechanism works by gradually releasing the active ingredient over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M, which encapsulates the medication.

What does 'improved patient compliance' mean?

'Improved patient compliance' means that patients are more likely to take their medication as prescribed. This is because the slow-release formulation reduces the frequency of dosing, making it easier for patients to adhere to their medication regimen.

What is Methocel E4M?

Methocel E4M is a type of controlled-release polymer. It is used in the formulation of certain medications to encapsulate the active ingredient and release it gradually over an extended period of time.

What does 'sustained therapeutic effects' mean?

'Sustained therapeutic effects' means that the medication continues to have its intended effect over a longer period of time. This is achieved through the slow-release formulation, which gradually releases the active ingredient.

How often do I need to take Dihydroergotamine Mesylate 3 mg Slow Release Capsules?

The frequency of dosing will depend on your doctor's instructions. However, the slow-release formulation is designed to reduce the frequency of dosing, making it easier for you to take your medication as prescribed.

Can I open the capsule to take the medication?

No, the capsule should not be opened. The medication is encapsulated in a controlled-release polymer, which is designed to gradually release the active ingredient over an extended period of time. Opening the capsule could interfere with this mechanism.

What should I do if I miss a dose?

If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses. Always consult your healthcare provider to ensure the information provided applies to your personal circumstances.

Related Formulas

Related Products
Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
NEW PRESCRIPTION ORDER FORM
1
Circle for steps.
Patient Information
2
Circle for steps.
Prescriber and Prescription Information
3
Circle for steps.
Fax order form to Bayview Pharmacy at 401-284-4506.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.